up home page bottom

Add a comment Bookmark

French German version Spanish version Italian version

headermask image

header image

Putting all our hope in one basket.

There has been a ton of hype going around the Cystic Fibrosis circles about a new drug developed by Vertex Pharmaceuticals.  Actually there are two drugs being studied, the names get confusing because the names are numbers (VX-770 and VX-809) to fix genetic mutations which are also numbers (G551D and delF508).  Both drugs are oral pills that are taken twice a day, both drugs work on the actual genetic mutation within the cell that causes all the troubles with CF at the cellular level.

Neither drug is a “cure” for CF.  To me a cure would mean that the CF mutation would be completely fixed with no further treatments needed, nor would the CF mutation be passed on through the future generations.  The Vertex drugs do neither of that.  Regardless, both drugs are hoped to be almost a miracle for us with CF if the drugs actually do what they are predicted to do.

Before I go on about these drugs (in a future post), I want to air a frustration I am having with the CF community specifically regarding the excitement and hope that this drug will be “the one” to fix all our problems.  Not trying to be Debbie Downer, and don’t get me wrong because yes I am excited about these drugs too, but it seems like everyone is getting wrapped up in the hype and is forgetting the reality that we have been here before specifically with the gene therapy studies of both Copernicus and Targeted Genetics.  Both companies developed a gene therapy (like early to mid ’90’s? maybe) that would also “fix” CF at the mutation/cellular level (but just in the lungs where most of the life shortening damage is done), both showed great promise, but both companies struggled to actually make things happen mostly because of funding and then some other issues… I feel right now the same excitement of the Copernicus and Targeted Genetics studies started up many years ago, but this time I have some reservations to throw all my hope into one drug.  To me, the Vertex drug it is not YET considered to be “the biggest breakthrough since finding the gene in 1989.”

The biggest fear I have is that if for any reason these drugs don’t make it to market or don’t work the way they hoped, or have some horrible side affect that does more harm than good, what is going to be the affect on CF research overall?  I fear that with the excitement and energy put into this one drug we are putting all our hope in one basket, all our effort in one place, that if this doesn’t work, we are screwed because we all assumed it would work.  I wonder if there are other drug companies that may have great ideas, who may be putting their ideas on hold waiting to see if this Vertex thing works out.

This really concerns me because I’m one of the adult Cystics who didn’t grow up with some of the major life extending drug therapies that the kids have now, like Pulmozyme and Hyper Tonic Saline.  I have no extra time to spare. I don’t have time to waste putting all hope and energy in one place.  So please don’t blame me for not getting all psyched up about the Vertex studies.  I will get pissed off when the media claims there is a new “cure” for CF, because if I have to take a pill twice a day (along with the others I am already taking due to permanent lung damage and because I have absolutely no pancreas left), yet if I have children of my own, or grandchildren if I am ever so lucky, there is still a chance they may have to do the same. That, to me, is no cure. So the fight for a cure must go on.

If you liked my post, feel free to subscribe to my rss feeds


4 Comments so far (Add 1 more)

  1. Hello – I’m a 32 year old with CF. I also share your frustration with treatments vs. cures, but we still have to take improvements in treatment whenever we can get them until a true cure comes.

    Another company called Actelion just completed a Phase II clinical trial of a drug called Miglustat (already FDA approved and marketed under the name Zavesca to treat two other diseases). Miglustat appears to help the CFTR protein make it to the cell membrane where it can function (like VX-809), and works for people who have two copies of the delta-508 mutation. The previous lab results on CF lung cell lines look very promising. The full results of the clinical trial are expected soon. So,the good news is there is at least one other horse in this race for treatments of the basic defect.

    Actelion website regarding the Miglustat clinical trial:
    http://www1.actelion.com/en/scientists/development-pipeline/phase-2/miglustat.page

    Or here for another story about it:
    http://www.bio-itworld.com/els/07/22/09/miglustat-corrects-cystic-fibrosis-cells.html

    1. Nathan on August 21st, 2009 at 11:16 am
  2. My daughter has CF and she’s 21 months old. Even though I am new to the CF world, I understand your fear about the Media claiming these medications as a “cure” and what that may do to research. There are so many more mutations, the CF research HAS to move forward. Even if these meds are exactly what they are being claimed to be, our fight is still not over. There are too many of us to be ignored.

    2. Sarah Kaupp on June 29th, 2009 at 7:26 pm
  3. To me, the passing on isn’t nearly as big of a deal as it would be to either repair lung damage over the years from infections or to not have rejection concerns from transplants.

    Asking my Dr. last time how I’m doing… really doing, he said, “You’re 30 and haven’t had a lung transplant. You’re doing great.”

    3. Jesse Petersen on June 26th, 2009 at 10:32 am
  4. I think a lot of people in the CF community forget that lung tissue cannot be repaired. So if a new drug does come out, it may not benefit everyone. Like myself, I have a ton of damage and the only thing that will help me is for science to figure out a way to reverse scar tissue.

    4. Stephanie on June 18th, 2009 at 2:27 pm

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*